Related Experiment Video

Updated: Feb 18, 2026

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

14.1K

Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions

Sukhdeep Bhogal, Vatsal Ladia, Puja Sitwala

    Current Problems in Cardiology
    |November 28, 2017
    PubMed

    Insights

    Cardiac amyloidosis, caused by abnormal protein buildup in the heart, has a poor prognosis. Early diagnosis of this underrecognized condition is crucial for effective management and improved survival outcomes.

    Area of Science:

    • Cardiology
    • Cardiovascular Medicine
    • Amyloidosis Research

    Background:

    • Cardiac amyloidosis results from abnormal amyloid protein deposition in heart tissue.
    • It is often underdiagnosed, particularly in patients with heart failure with preserved ejection fraction.
    • Delayed diagnosis leads to limited treatment options and poor prognosis.

    Purpose of the Study:

    • To review recent advancements in the evaluation of cardiac amyloidosis.
    • To summarize current management strategies for cardiac amyloidosis.
    • To discuss emerging and future therapeutic options for cardiac amyloidosis.

    Main Methods:

    • Literature review of recent studies on cardiac amyloidosis.
    • Analysis of diagnostic criteria and imaging techniques.
    • Synthesis of current and emerging treatment guidelines.

    Main Results:

    • Cardiac amyloidosis diagnosis is critical, especially in heart failure with preserved ejection fraction.
    • Early detection significantly impacts treatment accessibility and patient survival.
    • Prognosis is strongly linked to the extent of cardiac tissue involvement.

    Conclusions:

    • Early recognition of cardiac amyloidosis is essential to prevent irreversible cardiac damage.
    • Timely diagnosis and intervention can improve patient outcomes.
    • Ongoing research into novel treatments holds promise for managing cardiac amyloidosis.

    More Related Videos

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis06:33

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

    Published on: June 9, 2018

    8.1K
    Performing and Processing FNA of Anterior Fat Pad for Amyloid09:41

    Performing and Processing FNA of Anterior Fat Pad for Amyloid

    Published on: October 30, 2010

    56.3K

    Related Concept Videos

    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    611
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    638
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    539
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    489
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    605
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    298